UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000057836 |
|---|---|
| Receipt number | R000066090 |
| Scientific Title | Sensory evaluation test for pet animals (dogs) of Sasa senanensis Rehder concentrated extract |
| Date of disclosure of the study information | 2025/05/15 |
| Last modified on | 2025/05/13 16:59:51 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Sensory evaluation test for pet animals (dogs) of Sasa senanensis Rehder concentrated extract
Acronym
Sensory evaluation test for pet animals (dogs) of Sasa senanensis Rehder concentrated extract
Scientific Title
Sensory evaluation test for pet animals (dogs) of Sasa senanensis Rehder concentrated extract
Scientific Title:Acronym
Sensory evaluation test for pet animals (dogs) of Sasa senanensis Rehder concentrated extract
Region
| Japan |
Condition
Condition
Dog owners
Classification by specialty
| Not applicable |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
The effects of oral intake of concentrated extract of Sasa senanensis on fecal odor, body odor, and breath odor of dogs are verified by sensory evaluation by owners. In addition, as a preliminary study, the effects on symptoms of periodontal disease are investigated.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Change from baseline in sensory evaluation
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Prevention
Type of intervention
| Food |
Interventions/Control_1
Oral intake of test food for 4 weeks
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
[Owner]
1) People who own healthy spayed or neutered dogs (male or female) between 1 and 10 years of age
2) People who can perform sensory evaluations during the evaluation period
3) People who are concerned about the fecal odor and/or body odor of the test animals
4) People who wish to participate in this study and have given written consent
Key exclusion criteria
[Dogs]
1) Case those have been taking medicines regularly for the past 3 months prior to the start of the study
2) Case those currently have a serious illness (diabetes, heart disease, liver disease, kidney disease, cancer, etc.)
3) Case those have a history of serious illness (diabetes, heart disease, liver disease, kidney disease, cancer, etc.) or digestive system disease
4) Case those have a medical abnormality during a health check or other examination within one year prior to obtaining consent
5) Case those regularly take food, supplements, etc. that may affect the study
6) Case those regularly take food, supplements, etc. that may affect the study during the study period and are unable to stop taking them during the study period
7) Case those are deemsd ineligible to participate in this study for any other reason by the principal investigator
Target sample size
10
Research contact person
Name of lead principal investigator
| 1st name | Miho |
| Middle name | |
| Last name | Kurone |
Organization
Kurone clinic
Division name
Director
Zip code
206-0036
Address
25-6, Nakazawa2, Tama city, Tokyo, Japan
TEL
042-400-1092
kur54981@gmail.com
Public contact
Name of contact person
| 1st name | Miho |
| Middle name | |
| Last name | Kurone |
Organization
Kurone clinic
Division name
Director
Zip code
206-0036
Address
25-6, Nakazawa2, Tama city, Tokyo, Japan
TEL
042-400-1092
Homepage URL
kur54981@gmail.com
Sponsor or person
Institute
Kanamori Giken Co., Ltd
Institute
Department
Personal name
Funding Source
Organization
Self-Procurement
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Ethics Review Committee of Watanabe Hospital
Address
5-16, Haneda1, Ota-ku, Tokyo, Japan
Tel
03-3741-0223
wnb@cto-net.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2025 | Year | 05 | Month | 15 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2025 | Year | 05 | Month | 07 | Day |
Date of IRB
Anticipated trial start date
| 2025 | Year | 07 | Month | 01 | Day |
Last follow-up date
| 2025 | Year | 09 | Month | 30 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2025 | Year | 05 | Month | 12 | Day |
Last modified on
| 2025 | Year | 05 | Month | 13 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066090
